The trabecular meshwork: Structure, function and clinical implications. A review of the literature

Tham, 2014, Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis, Ophthalmology, 121, 2081, 10.1016/j.ophtha.2014.05.013

Gordon, 1999, The ocular hypertension treatment study: design and baseline description of the participants, Arch Ophthalmol, 117, 573, 10.1001/archopht.117.5.573

Stamer, 2017, The many faces of the trabecular meshwork cell, Exp Eye Res, 158, 112, 10.1016/j.exer.2016.07.009

Vranka, 2015, Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma, Exp Eye Res, 133, 112, 10.1016/j.exer.2014.07.014

Cvekl, 2004, Anterior eye development and ocular mesenchyme, Bioessays, 26, 374, 10.1002/bies.20009

Lütjen-Drecoll, 1999, Functional morphology of the trabecular meshwork in primate eyes, Prog Retin Eye Res, 18, 91, 10.1016/S1350-9462(98)00011-1

Gong, 1996, Morphology of the aqueous outflow pathway, Microsc Res Tech, 33, 336, 10.1002/(SICI)1097-0029(19960301)33:4<336::AID-JEMT4>3.0.CO;2-N

Buller, 1994, Segmental variability of the trabecular meshwork in normal and glaucomatous eyes, Invest Ophthalmol Vis Sci, 35, 3841

Johnson, 2001, How does nonpenetrating glaucoma surgery work? Aqueous outflow resistance and glaucoma surgery, J Glaucoma, 10, 55, 10.1097/00061198-200102000-00011

Renard, 2014, 250

Tamm, 2009, The trabecular meshwork outflow pathways: structural and functional aspects, Exp Eye Res, 88, 648, 10.1016/j.exer.2009.02.007

Shuman, 1988, Tissue plasminogen activator in cultured human trabecular meshwork cells. Predominance of enzyme over plasminogen activator inhibitor, Invest Ophthalmol Vis Sci, 29, 401

Lynch, 1987, Expression of HLA class I and II antigens on cells of the human trabecular meshwork, Ophthalmology, 94, 851, 10.1016/S0161-6420(87)33539-0

Latina, 1988, Immunohistochemical staining of the human anterior segment. Evidence that resident cells play a role in immunologic responses, Arch Ophthalmol, 106, 95, 10.1001/archopht.1988.01060130101037

Coupland, 1994, Immunohistochemistry study of the glaucomatous and normal human trabecular meshwork, Ger J Ophthalmol, 3, 168

Tripathi, 1990, Expression of HLA by the human trabecular meshwork and corneal endothelium, Exp Eye Res, 51, 269, 10.1016/0014-4835(90)90023-N

Shifera, 2010, Constitutive secretion of chemokines by cultured human trabecular meshwork cells, Exp Eye Res, 91, 42, 10.1016/j.exer.2010.04.001

Alvarado, 2010, Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty, Arch Ophthalmol, 128, 731, 10.1001/archophthalmol.2010.85

Li, 2020, Gap junction connexin43 is a key element in mediating phagocytosis activity in human trabecular meshwork cells, Int J Physiol Pathophysiol Pharmacol, 12, 25

Peotter, 2016, Involvement of Tiam1, RhoG and ELMO2/ILK in Rac1-mediated phagocytosis in human trabecular meshwork cells, Exp Cell Res, 347, 301, 10.1016/j.yexcr.2016.08.009

Weinreb, 2020, Matrix metalloproteinases and glaucoma treatment, J Ocul Pharmacol Ther, 36, 208, 10.1089/jop.2019.0146

Yun, 2016, Stem cells in the trabecular meshwork for regulating intraocular pressure, J Ocul Pharmacol Ther, 32, 253, 10.1089/jop.2016.0005

Du, 2012, Multipotent stem cells from trabecular meshwork become phagocytic TM cells, Invest Ophthalmol Vis Sci, 53, 1566, 10.1167/iovs.11-9134

Tamm, 2015, Intraocular pressure and the mechanisms involved in resistance of the aqueous humor flow in the trabecular meshwork outflow pathways, 134, 301

Knepper, 2010, Chapter 22 – Abnormal trabecular meshwork outflow, 171

Ueda, 2002, Distribution of myocilin and extracellular matrix components in the juxtacanalicular tissue of human eyes, Invest Ophthalmol Vis Sci, 43, 1068

Keller, 2009, Extracellular matrix turnover and outflow resistance, Exp Eye Res, 88, 676, 10.1016/j.exer.2008.11.023

Fautsch, 2006, Aqueous humor outflow: what do we know? Where will it lead us?, Invest Ophthalmol Vis Sci, 47, 4181, 10.1167/iovs.06-0830

Winkler, 2014, Effects of prostaglandin analogues on aqueous humor outflow pathways, J Ocul Pharmacol Ther, 30, 102, 10.1089/jop.2013.0179

Grant, 1958, Further studies on facility of flow through the trabecular meshwork, AMA Arch Ophthalmol, 60, 523, 10.1001/archopht.1958.00940080541001

Rohen, 1981, The fine structure of the cribriform meshwork in normal and glaucomatous eyes as seen in tangential sections, Invest Ophthalmol Vis Sci, 21, 574

Wang, 2017, Trabecular meshwork stiffness in glaucoma, Exp Eye Res, 158, 3, 10.1016/j.exer.2016.07.011

Tektas, 2009, Structural changes of the trabecular meshwork in different kinds of glaucoma, Exp Eye Res, 88, 769, 10.1016/j.exer.2008.11.025

Liton, 2005, Cellular senescence in the glaucomatous outflow pathway, Exp Gerontol, 40, 745, 10.1016/j.exger.2005.06.005

Liu, 2018, Aging and ocular tissue stiffness in glaucoma, Surv Ophthalmol, 63, 56, 10.1016/j.survophthal.2017.06.007

Hamard, 2002, Confocal microscopic examination of trabecular meshwork removed during ab externo trabeculectomy, Br J Ophthalmol, 86, 1046, 10.1136/bjo.86.9.1046

Tian, 2009, The role of the actomyosin system in regulating trabecular fluid outflow, Exp Eye Res, 88, 713, 10.1016/j.exer.2008.08.008

Prendes, 2013, The role of transforming growth factor β in glaucoma and the therapeutic implications, Br J Ophthalmol, 97, 680, 10.1136/bjophthalmol-2011-301132

Webber, 2016, Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork, Exp Eye Res, 148, 97, 10.1016/j.exer.2016.04.007

Pervan, 2017, Smad-independent TGF-β2 signaling pathways in human trabecular meshwork cells, Exp Eye Res, 158, 137, 10.1016/j.exer.2016.07.012

Tripathi, 1977, Pathologic anatomy in the outflow pathway of aqueous humour in chronic simple glaucoma, Exp Eye Res, 25, 403, 10.1016/S0014-4835(77)80035-3

Picht, 2001, Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development, Graefes Arch Clin Exp Ophthalmol, 239, 199, 10.1007/s004170000252

Fuchshofer, 2009, Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: identification of Smad7 as a critical inhibitor of TGF-beta2 signaling, Exp Eye Res, 88, 1020, 10.1016/j.exer.2009.01.002

Tovar-Vidales, 2016, Human trabecular meshwork cells express BMP antagonist mRNAs and proteins, Exp Eye Res, 147, 156, 10.1016/j.exer.2016.05.004

Hernandez, 2018, BMP and activin membrane bound inhibitor regulates the extracellular matrix in the trabecular meshwork, Invest Ophthalmol Vis Sci, 59, 2154, 10.1167/iovs.17-23282

Wordinger, 2007, Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma, Invest Ophthalmol Vis Sci, 48, 1191, 10.1167/iovs.06-0296

McDowell, 2015, Gremlin induces ocular hypertension in mice through smad3-dependent signaling, Invest Ophthalmol Vis Sci, 56, 5485, 10.1167/iovs.15-16993

Mody, 2017, Role of ID proteins in BMP4 inhibition of profibrotic effects of TGF-β2 in human TM cells, Invest Ophthalmol Vis Sci, 58, 849, 10.1167/iovs.16-20472

Benoist d’Azy, 2016, Oxidative and anti-oxidative stress markers in chronic glaucoma: a systematic review and meta-analysis, PLoS ONE, 11, e0166915, 10.1371/journal.pone.0166915

Zhao, 2016, Oxidative stress in the trabecular meshwork (Review), Int J Mol Med, 38, 995, 10.3892/ijmm.2016.2714

Nita, 2016, The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults, Oxid Med Cell Longev, 2016, 3164734, 10.1155/2016/3164734

Rao, 2019, Mitochondrial-targeted antioxidants attenuate TGF-β2 signaling in human trabecular meshwork cells, Invest Ophthalmol Vis Sci, 60, 3613, 10.1167/iovs.19-27542

Hamanaka, 2011, Histopathology of the trabecular meshwork and Schlemm's canal in primary angle-closure glaucoma, Invest Ophthalmol Vis Sci, 52, 8849, 10.1167/iovs.11-7591

Sihota, 2012, Scanning electron microscopy of the trabecular meshwork: understanding the pathogenesis of primary angle closure glaucoma, Indian J Ophthalmol, 60, 183, 10.4103/0301-4738.95868

Tawara, 2008, Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid-induced glaucoma, Graefes Arch Clin Exp Ophthalmol, 246, 1021, 10.1007/s00417-008-0800-0

Clark, 2005, Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue, Cell Motil Cytoskeleton, 60, 83, 10.1002/cm.20049

Raghunathan, 2015, Dexamethasone stiffens trabecular meshwork, trabecular meshwork cells, and matrix, Invest Ophthalmol Vis Sci, 56, 4447, 10.1167/iovs.15-16739

Polansky, 2000, Regulation of TIGR/MYOC gene expression in human trabecular meshwork cells, Eye (Lond), 14, 503, 10.1038/eye.2000.137

Filla, 2002, In vitro localization of TIGR/MYOC in trabecular meshwork extracellular matrix and binding to fibronectin, Invest Ophthalmol Vis Sci, 43, 151

Sakai, 2007, Mitochondrial association of myocilin, product of a glaucoma gene, in human trabecular meshwork cells, J Cell Physiol, 213, 775, 10.1002/jcp.21147

Yam, 2007, Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma, Am J Pathol, 170, 100, 10.2353/ajpath.2007.060806

Campbell, 1979, Pigmentary dispersion and glaucoma. A new theory, Arch Ophthalmol, 97, 1667, 10.1001/archopht.1979.01020020235011

Scott, 2011, YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial, Ophthalmology, 118, 468, 10.1016/j.ophtha.2010.07.026

Wang, 2019, Impact of pigment dispersion on trabecular meshwork cells, Graefes Arch Clin Exp Ophthalmol, 257, 1217, 10.1007/s00417-019-04300-7

Dang, 2018, A porcine ex vivo model of pigmentary glaucoma, Sci Rep, 8, 5468, 10.1038/s41598-018-23861-x

Wang, 2013, Rho/Rho-associated kinase pathway in glaucoma (Review), Int J Oncol, 43, 1357, 10.3892/ijo.2013.2100

Dang, 2019, RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis, Graefes Arch Clin Exp Ophthalmol, 257, 101, 10.1007/s00417-018-4175-6

Schweitzer, 2018, Pseudoexfoliation syndrome and pseudoexfoliation glaucoma, J Fr Ophtalmol, 41, 78, 10.1016/j.jfo.2017.09.003

Challa, 2018, Composition of exfoliation material, J Glaucoma, 27, S29, 10.1097/IJG.0000000000000917

Sharon, 2017, Uveitic glaucoma: long-term clinical outcome and risk factors for progression, Ocul Immunol Inflamm, 25, 740, 10.1080/09273948.2016.1255341

Baneke, 2016, The pathogenesis of raised intraocular pressure in Uveitis, Current Eye Research, 41, 137, 10.3109/02713683.2015.1017650

Tektas, 2011, Morphological changes of trabeculectomy specimens in different kinds of uveitic glaucoma, Curr Eye Res, 36, 442, 10.3109/02713683.2011.566409

Souissi, 2006, Kraiem Etiopathogeny of intraocular pressure modifications in uveitis, J Fr Ophtalmol, 29, 456, 10.1016/S0181-5512(06)77711-7

Baudouin, 1999, Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies, Ophthalmology, 106, 556, 10.1016/S0161-6420(99)90116-1

Brignole-Baudouin, 2012, A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits, PLoS ONE, 7, e50180, 10.1371/journal.pone.0050180

Hamard, 2003, In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells, Graefes Arch Clin Exp Ophthalmol, 241, 1037, 10.1007/s00417-003-0777-7

Baudouin, 2012, In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis), Trans Am Ophthalmol Soc, 110, 40

Denoyer, 2012, CXCR3 antagonism of SDF-1 (5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension, PLoS ONE, 7, e37873, 10.1371/journal.pone.0037873

Bouchemi, 2017, Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma, Toxicol In Vitro, 41, 21, 10.1016/j.tiv.2017.02.006

Kass, 2002, The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma, Arch Ophthalmol, 120, 701, 10.1001/archopht.120.6.701

Heijl, 2002, Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial, Arch Ophthalmol, 120, 1268, 10.1001/archopht.120.10.1268

2000, The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators, Am J Ophthalmol, 130, 429, 10.1016/S0002-9394(00)00538-9

Bahler, 2008, Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments, Am J Ophthalmol, 145, 114, 10.1016/j.ajo.2007.09.001

Kalouche, 2016, Activation of prostaglandin FP and EP2 receptors differently modulates myofibroblast transition in a model of adult primary human trabecular meshwork cells, Invest Ophthalmol Vis Sci, 57, 1816, 10.1167/iovs.15-17693

Amano, 2010, Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity, Cytoskeleton (Hoboken), 67, 545, 10.1002/cm.20472

Pattabiraman, 2010, Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells, Am J Physiol Cell Physiol, 298, C749, 10.1152/ajpcell.00317.2009

Torrejon, 2016, TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor, Sci Rep, 38319, 10.1038/srep38319

Maruyama, 2020, Safety and efficacy of long-term ripasudil 0.4% instillation for the reduction of intraocular pressure in japanese open-angle glaucoma patients, J Ocul Pharmacol Ther, 36, 229, 10.1089/jop.2019.0125

US Department of Health and Human Services, Food and Drug Administration, 2017

Kopczynski, 2018, Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension, Drugs Today, 54, 467, 10.1358/dot.2018.54.8.2849627

Serle, 2018, Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2), Am J Ophthalmol, 186, 116, 10.1016/j.ajo.2017.11.019

Sakamoto, 2019, Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% ripasudil ophthalmic solution clinical trial, Sci Rep, 9, 3755, 10.1038/s41598-019-40255-9

Asrani, 2020, Fixed-dose combination of netarsudil and latanoprost in ocular hypertension and open-angle glaucoma: pooled efficacy/safety analysis of phase 3 MERCURY-1 and -2, Adv Ther, 37, 1620, 10.1007/s12325-020-01277-2

Radell, 2019, Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension, Drugs Today, 55, 563, 10.1358/dot.2019.55.9.3039670

Latina, 1995, Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions, Exp Eye Res, 60, 359, 10.1016/S0014-4835(05)80093-4

Alvarado, 2005, A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells, Br J Ophthalmol, 89, 1500, 10.1136/bjo.2005.081307

Kramer, 2001, Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes, Ophthalmology, 108, 773, 10.1016/S0161-6420(00)00660-6

Latina, 2005, Selective laser trabeculoplasty, Ophthalmol Clin North Am, 18, 409, 10.1016/j.ohc.2005.05.005

Landers, 2012, A twenty-year follow-up study of trabeculectomy: risk factors and outcomes, Ophthalmology, 119, 694, 10.1016/j.ophtha.2011.09.043

Hamard, 2002, Non penetrating filtering surgery, evolution and results, J Fr Ophtalmol, 25, 527

Kirwan, 2013, Trabeculectomy in the 21st century: a multicenter analysis, Ophthalmology, 120, 2532, 10.1016/j.ophtha.2013.07.049

Gedde, 2018, Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up, Ophthalmology, 125, 650, 10.1016/j.ophtha.2018.02.003

Cillino, 2008, Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up, Ophthalmologica, 222, 81, 10.1159/000112623

Andrew, 2020, A review of aqueous outflow resistance and its relevance to microinvasive glaucoma surgery, Surv Ophthalmol, 65, 18, 10.1016/j.survophthal.2019.08.002

Lavia, 2017, Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis, PLoS ONE, 12, e0183142, 10.1371/journal.pone.0183142

Wellik, 2015, A review of the iStent (®) trabecular micro-bypass stent: safety and efficacy, Clin Ophthalmol, 9, 677, 10.2147/OPTH.S57217

Pfeiffer, 2015, A Randomized trial of a Schlemm's canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma, Ophthalmology, 122, 1283, 10.1016/j.ophtha.2015.03.031

Dorairaj, 2018, A multicenter retrospective comparison of goniotomy versus trabecular bypass device implantation in glaucoma patients undergoing cataract extraction, Clin Ophthalmol, 12, 791, 10.2147/OPTH.S158403

Körber, 2017, Canaloplasty ab interno – a minimally invasive alternative, Klin Monbl Augenheilkd, 234, 991, 10.1055/s-0042-123829

Grover, 2014, Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: technique report and preliminary results, Ophthalmology, 121, 855, 10.1016/j.ophtha.2013.11.001

Richter, 2016, Minimally invasive glaucoma surgery: current status and future prospects, Clin Ophthalmol, 10, 189

Perinchery, 2016, High resolution iridocorneal angle imaging system by axicon lens assisted gonioscopy, Sci Rep, 6, 30844, 10.1038/srep30844

Yasuno, 2010, Visibility of trabecular meshwork by standard and polarization-sensitive optical coherence tomography, J Biomed Opt, 15, 061705, 10.1117/1.3499421

King, 2019, High-resolution, adaptive optics imaging of the human trabecular meshwork in vivo, Transl Vis Sci Technol, 8, 5, 10.1167/tvst.8.5.5

Lin, 2016, Curcumin protects trabecular meshwork cells from oxidative stress, Invest Ophthalmol Vis Sci, 57, 4327, 10.1167/iovs.16-19883

Kalouche, 2016, Prostaglandin EP2 receptor signaling protects human trabecular meshwork cells from apoptosis induced by ER stress through down-regulation of p53, Biochim Biophys Acta, 1863, 2322, 10.1016/j.bbamcr.2016.06.008

Wang, 2020, Stem cells from trabecular meshwork cells can secrete extracellular matrix, Biochem Biophys Res Commun, 523, 522, 10.1016/j.bbrc.2019.12.080

Kelley, 2009, Stem cells in the trabecular meshwork: present and future promises, Exp Eye Res, 88, 747, 10.1016/j.exer.2008.10.024

Roubeix, 2015, Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma, Stem Cell Res Ther, 6, 177, 10.1186/s13287-015-0168-0

Ding, 2014, Induction of trabecular meshwork cells from induced pluripotent stem cells, Invest Ophthalmol Vis Sci, 55, 7065, 10.1167/iovs.14-14800

Zhu, 2020, Transplantation of iPSC-TM stimulates division of trabecular meshwork cells in human eyes, Sci Rep, 10, 2905, 10.1038/s41598-020-59941-0

Zhu, 2017, Restoration of aqueous humor outflow following transplantation of iPSC-derived trabecular meshwork cells in a transgenic mouse model of glaucoma, Invest Ophthalmol Vis Sci, 58, 2054, 10.1167/iovs.16-20672

Castro, 2019, Trabecular meshwork regeneration – A potential treatment for glaucoma, Curr Ophthalmol Rep, 7, 80, 10.1007/s40135-019-00203-2